{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:32:05Z","timestamp":1784691125849,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010993","name":"Irish Nephrology Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010993","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jbo.2025.100720","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T17:11:13Z","timestamp":1761412273000},"page":"100720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Bone disease burden does not impact overall survival in newly diagnosed patients with multiple myeloma \u2212 a single center, retrospective imaging analysis on 119 patients"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5133-1422","authenticated-orcid":false,"given":"Evangelos","family":"Terpos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Koutoulidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Ntanasis-Stathopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos","family":"Mavropoulos-Papoudas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Douka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gavriatopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Malandrakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Spiliopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foteini","family":"Theodorakakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Fotiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalini","family":"Migkou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Kanellias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Eleutherakis-Papaiakovou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Kastritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia-Angela","family":"Moulopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meletios A","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2025.100720_b0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/hematolrep16010009","article-title":"Prevalence, outcomes and impact of disease-related complications in the survival of Multiple Myeloma patients","volume":"16","author":"Tothong","year":"2024","journal-title":"Hematol. Rep."},{"key":"10.1016\/j.jbo.2025.100720_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11113088","article-title":"Newly diagnosed multiple myeloma patients with skeletal-related events and abnormal MRI pattern have poor survival outcomes: a prospective study on 370 patients","volume":"11","author":"Kanellias","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jbo.2025.100720_b0015","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/S1470-2045(20)30559-3","article-title":"Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group","volume":"22","author":"Terpos","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jbo.2025.100720_b0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41408-018-0124-1","article-title":"Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group","volume":"8","author":"Moulopoulos","year":"2018","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.jbo.2025.100720_b0025","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/S1470-2045(19)30309-2","article-title":"International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders","volume":"20","author":"Hillengass","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jbo.2025.100720_b0030","doi-asserted-by":"crossref","first-page":"e599","DOI":"10.1038\/bcj.2017.78","article-title":"Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group","volume":"7","author":"Hillengass","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.jbo.2025.100720_b0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41408-020-00360-9","article-title":"The role of low dose whole body CT in the detection of progression of patients with smoldering multiple myeloma","volume":"10","author":"Gavriatopoulou","year":"2020","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.jbo.2025.100720_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14072224","article-title":"Yearly Assessment of bone disease in patients with asymptomatic multiple myeloma identifies early progression events and should be the standard clinical practice","volume":"14","author":"Ntanasis-Stathopoulos","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jbo.2025.100720_b0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/ejh.13749","article-title":"A prospective study of Skeletal survey versus Low-dose whole-body CT for Osteolytic lesions in Multiple Myeloma","volume":"108","author":"Gundesen","year":"2022","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.jbo.2025.100720_b0050","article-title":"Whole body low dose computed tomography (WBLDCT) can be comparable to whole-body magnetic resonance imaging (WBMRI) in the assessment of multiple myeloma","volume":"11","author":"Ippolito","year":"2021","journal-title":"Diagnostics (basel)"},{"key":"10.1016\/j.jbo.2025.100720_b0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00256-008-0607-4","article-title":"Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI)","volume":"38","author":"Gleeson","year":"2009","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.jbo.2025.100720_b0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00256-024-04733-0","article-title":"Whole-body low-dose computed tomography in patients with newly diagnosed multiple myeloma predicts cytogenetic risk: a deep learning radiogenomics study","volume":"54","author":"Faghani","year":"2025","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.jbo.2025.100720_b0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1756-9966-27-11","article-title":"Effect of pathologic fractures on survival in multiple myeloma patients: a case control study","volume":"27","author":"Sonmez","year":"2008","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jbo.2025.100720_b0070","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3324\/haematol.2019.230011","article-title":"Fractures and survival in multiple myeloma: results from a population-based study","volume":"105","author":"Thorsteinsdottir","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jbo.2025.100720_b0075","first-page":"147","article-title":"Detection of skeletal lesions by whole body multidetector computed tomography in multiple myeloma has no impact on long-term outcomes post autologous hematopoietic cell transplantation","volume":"3","author":"Wirk","year":"2012","journal-title":"World J Oncol"},{"key":"10.1016\/j.jbo.2025.100720_b0080","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1182\/blood-2024-205539","article-title":"Spinal bracing: a novel non-invasive technique to prevent spinal fractures and preserve spinal stability in patients with multiple myeloma","volume":"144","author":"Kanellias","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jbo.2025.100720_b0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jor.2023.03.008","article-title":"The incidence of vertebral compression fractures and spinal instability in newly diagnosed multiple myeloma patients","volume":"38","author":"Zijlstra","year":"2023","journal-title":"J. Orthop."},{"key":"10.1016\/j.jbo.2025.100720_b0090","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/02688697.2020.1823941","article-title":"Changes of inflammatory cytokines in vertebral compression fractures patients with percutaneous balloon kyphoplasty","volume":"38","author":"Zhang","year":"2024","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.jbo.2025.100720_b0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jbo.2013.04.001","article-title":"Myeloma bone disease: Pathophysiology and management","volume":"2","author":"Silbermann","year":"2013","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.jbo.2025.100720_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2025.100680","article-title":"Treatment of myeloma bone disease: when, how often, and for how long?","volume":"52","author":"Gundesen","year":"2025","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.jbo.2025.100720_b0105","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/bjh.17256","article-title":"Controversies in the use of new bone-modifying therapies in multiple myeloma","volume":"193","author":"Terpos","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jbo.2025.100720_b0110","doi-asserted-by":"crossref","first-page":"E226","DOI":"10.1002\/ajh.27001","article-title":"Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed\/refractory multiple myeloma and severe renal impairment or on dialysis: the DARE study","volume":"98","author":"Kastritis","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jbo.2025.100720_b0115","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ajh.27206","article-title":"Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: final results of the phase 2 study DARIA","volume":"99","author":"Terpos","year":"2024","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jbo.2025.100720_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112768","article-title":"Daratumumab improves bone turnover in relapsed\/refractory multiple myeloma; phase 2 study \u201cREBUILD\u201d","volume":"14","author":"Terpos","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbo.2025.100720_b0125","article-title":"Carfilzomib improves bone metabolism in patients with advanced relapsed\/refractory multiple myeloma: results of the CarMMa study","volume":"13","author":"Terpos","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbo.2025.100720_b0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41408-020-0297-2","volume":"10","author":"Gavriatopoulou","year":"2020","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.jbo.2025.100720_b0135","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41467-017-00296-y","article-title":"Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing","volume":"8","author":"Rasche","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbo.2025.100720_b0140","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/ncomms9983","article-title":"Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche","volume":"6","author":"Lawson","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbo.2025.100720_b0145","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2214\/AJR.20.23204","article-title":"Whole-body low-dose CT in multiple myeloma: diagnostic value of appendicular medullary patterns of attenuation","volume":"216","author":"Koutoulidis","year":"2021","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.jbo.2025.100720_b0150","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1200\/JCO.2017.72.2975","volume":"35","author":"Moreau","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2025.100720_b0155","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.critrevonc.2018.02.012","article-title":"Comparison of whole body magnetic resonance imaging (WBMRI) to whole body computed tomography (WBCT) or (18)F-fluorodeoxyglucose positron emission tomography\/CT ((18)F-FDG PET\/CT) in patients with myeloma: systematic review of diagnostic performance","volume":"124","author":"Gariani","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jbo.2025.100720_b0160","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.2021210048","article-title":"Prospective evaluation of whole-body MRI versus FDG PET\/CT for lesion detection in participants with myeloma","volume":"3","author":"Messiou","year":"2021","journal-title":"Radiol. Imaging Cancer"},{"key":"10.1016\/j.jbo.2025.100720_b0165","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/RLU.0000000000003773","article-title":"Prognostic impact of metabolic heterogeneity in patients with newly diagnosed multiple myeloma using 18F-FDG PET\/CT","volume":"46","author":"Terao","year":"2021","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.jbo.2025.100720_b0170","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/RLU.0000000000003512","article-title":"Agreement between 18F-FDG PET\/CT and whole-body magnetic resonance compared with skeletal survey for initial staging and response at end-of-treatment evaluation of patients with multiple myeloma","volume":"46","author":"Gomez Leon","year":"2021","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.jbo.2025.100720_b0175","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1007\/s00259-020-05182-2","article-title":"Comparison of the diagnostic performance and impact on management of 18F-FDG PET\/CT and whole-body MRI in multiple myeloma","volume":"48","author":"Westerland","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jbo.2025.100720_b0180","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s00277-020-04265-2","article-title":"Prospective comparison of 18-FDG PET\/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma","volume":"99","author":"Mesguich","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.jbo.2025.100720_b0185","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2214\/AJR.18.20989","article-title":"Comparison of whole-body DWI and (18)F-FDG PET\/CT for detecting intramedullary and extramedullary lesions in multiple myeloma","volume":"213","author":"Chen","year":"2019","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.jbo.2025.100720_b0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1148\/radiol.211388","article-title":"Comparison of MRI features of fat fraction and ADC for early treatment response assessment in participants with multiple myeloma","volume":"304","author":"Koutoulidis","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.jbo.2025.100720_b0195","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231817","article-title":"MRI-based zero echo time and black bone pseudo-CT compared with whole-body CT to detect osteolytic lesions in multiple myeloma","volume":"313","author":"Lecouvet","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.jbo.2025.100720_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116857","article-title":"Identification of focal lesion characteristics in MRI which indicate presence of corresponding osteolytic lesion in CT in patients with multiple myeloma","volume":"175","author":"Hildenbrand","year":"2023","journal-title":"Bone"},{"key":"10.1016\/j.jbo.2025.100720_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110493","article-title":"Multi-parametric whole-body MRI evaluation discerns vital from non-vital multiple myeloma lesions as validated by (18)F-FDG and (11)C-methionine PET\/CT","volume":"155","author":"Heidemeier","year":"2022","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.jbo.2025.100720_b0210","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00259-024-06668-z","article-title":"Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [(18)F]FDG PET\/CT predicts survival in multiple myeloma","volume":"51","author":"Sachpekidis","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jbo.2025.100720_b0215","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/MNM.0000000000001608","article-title":"Relation of whole-body metabolic tumor volume and total lesion glycolysis on fluorodeoxyglucose PET\/computed tomography with clinical and laboratory parameters in newly diagnosed multiple myeloma","volume":"43","author":"Goksel","year":"2022","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.jbo.2025.100720_b0220","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/MNM.0000000000001470","article-title":"Intensity of bone involvement: a quantitative 18F-FDG PET\/CT evaluation for monitoring outcome of multiple myeloma","volume":"42","author":"Takahashi","year":"2021","journal-title":"Nucl. Med. Commun."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137425000612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137425000612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T12:26:06Z","timestamp":1765023966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137425000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"alternative-id":["S2212137425000612"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2025.100720","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone disease burden does not impact overall survival in newly diagnosed patients with multiple myeloma \u2212 a single center, retrospective imaging analysis on 119 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2025.100720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100720"}}